Skip to main content
. 2017 Nov 1;18(11):2301. doi: 10.3390/ijms18112301

Figure 4.

Figure 4

Intratumour heterogeneity of HPSE expression in glioblastoma. (A) Immunostaining of GBM tumours using anti-HPSE antibodies. Patients 7 and 8; Fields 1,2,3-observation fields of the histological preparation; counterstaining with Hematoxylin; magnification ×400; (B) Semi-quantitative analysis of anti-HPSE staining intensities in different observation fields. Bars represent the mean from triplicate experiments ± SD (Origin 8.5; OriginLab Corporation, Northampton, USA); 7, 8-patients.